BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18339699)

  • 1. Development of a multiplexed urine assay for prostate cancer diagnosis.
    Vener T; Derecho C; Baden J; Wang H; Rajpurohit Y; Skelton J; Mehrotra J; Varde S; Chowdary D; Stallings W; Leibovich B; Robin H; Pelzer A; Schäfer G; Auprich M; Mannweiler S; Amersdorfer P; Mazumder A
    Clin Chem; 2008 May; 54(5):874-82. PubMed ID: 18339699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection.
    Rogers CG; Gonzalgo ML; Yan G; Bastian PJ; Chan DY; Nelson WG; Pavlovich CP
    J Urol; 2006 Nov; 176(5):2280-4. PubMed ID: 17070312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients.
    Moreira-Barbosa C; Barros-Silva D; Costa-Pinheiro P; Torres-Ferreira J; Constâncio V; Freitas R; Oliveira J; Antunes L; Henrique R; Jerónimo C
    Clin Epigenetics; 2018 Oct; 10(1):132. PubMed ID: 30373654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of a single assay for both type III and type VI TMPRSS2:ERG fusions in noninvasive prediction of prostate biopsy outcome.
    Clark JP; Munson KW; Gu JW; Lamparska-Kupsik K; Chan KG; Yoshida JS; Kawachi MH; Crocitto LE; Wilson TG; Feng Z; Smith SS
    Clin Chem; 2008 Dec; 54(12):2007-17. PubMed ID: 18948370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting prostate biopsy result in men with prostate specific antigen 2.0 to 10.0 ng/ml using an investigational prostate cancer methylation assay.
    Baden J; Adams S; Astacio T; Jones J; Markiewicz J; Painter J; Trust C; Wang Y; Green G
    J Urol; 2011 Nov; 186(5):2101-6. PubMed ID: 21944123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies.
    Trock BJ; Brotzman MJ; Mangold LA; Bigley JW; Epstein JI; McLeod D; Klein EA; Jones JS; Wang S; McAskill T; Mehrotra J; Raghavan B; Partin AW
    BJU Int; 2012 Jul; 110(1):56-62. PubMed ID: 22077694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent methylation of RASSF1 and RARB in urine sediments from patients with early stage prostate cancer.
    Daniūnaitė K; Berezniakovas A; Jankevičius F; Laurinavičius A; Lazutka JR; Jarmalaitė S
    Medicina (Kaunas); 2011; 47(3):147-53. PubMed ID: 21822036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Diagnostic of Prostate Cancer From Body Fluids Using Methylation-Specific PCR (MS-PCR) Method.
    Minciu R; Dumache R; Gheorghe P; Daminescu L; Rogobete AF; Ionescu D
    Clin Lab; 2016; 62(6):1183-6. PubMed ID: 27468582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of genetic and epigenetic alterations in urine samples as diagnostic markers for prostate cancer.
    Dimitriadis E; Kalogeropoulos T; Velaeti S; Sotiriou S; Vassiliou E; Fasoulis L; Klapsas V; Synesiou M; Apostolaki A; Trangas T; Pandis N
    Anticancer Res; 2013 Jan; 33(1):191-7. PubMed ID: 23267145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.
    Gonzalgo ML; Pavlovich CP; Lee SM; Nelson WG
    Clin Cancer Res; 2003 Jul; 9(7):2673-7. PubMed ID: 12855646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter evaluation of an investigational prostate cancer methylation assay.
    Baden J; Green G; Painter J; Curtin K; Markiewicz J; Jones J; Astacio T; Canning S; Quijano J; Guinto W; Leibovich BC; Nelson JB; Vargo J; Wang Y; Wuxiong C
    J Urol; 2009 Sep; 182(3):1186-93. PubMed ID: 19625061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer.
    Zhao F; Olkhov-Mitsel E; Kamdar S; Jeyapala R; Garcia J; Hurst R; Hanna MY; Mills R; Tuzova AV; O'Reilly E; Kelly S; Cooper C; ; Brewer D; Perry AS; Clark J; Fleshner N; Bapat B
    Clin Epigenetics; 2018 Nov; 10(1):147. PubMed ID: 30470249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.
    Yamamoto N; Nakayama T; Kajita M; Miyake T; Iwamoto T; Kim SJ; Sakai A; Ishihara H; Tamaki Y; Noguchi S
    Breast Cancer Res Treat; 2012 Feb; 132(1):165-73. PubMed ID: 21594664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.
    Woodson K; O'Reilly KJ; Hanson JC; Nelson D; Walk EL; Tangrea JA
    J Urol; 2008 Feb; 179(2):508-11; discussion 511-2. PubMed ID: 18076912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies.
    Van Neste L; Partin AW; Stewart GD; Epstein JI; Harrison DJ; Van Criekinge W
    Prostate; 2016 Sep; 76(12):1078-87. PubMed ID: 27121847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
    Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D
    Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer.
    Jerónimo C; Usadel H; Henrique R; Silva C; Oliveira J; Lopes C; Sidransky D
    Urology; 2002 Dec; 60(6):1131-5. PubMed ID: 12475696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene promoter methylation and its potential relevance in early prostate cancer diagnosis.
    Steiner I; Jung K; Schatz P; Horns T; Wittschieber D; Lein M; Dietel M; Erbersdobler A
    Pathobiology; 2010; 77(5):260-6. PubMed ID: 21116117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis.
    Gonzalgo ML; Nakayama M; Lee SM; De Marzo AM; Nelson WG
    Urology; 2004 Feb; 63(2):414-8. PubMed ID: 14972513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.